Life science CEOs operate under intense scrutiny and pressure to deliver scientific innovation while managing investor expectations and strategic business decisions. A highly engaged and effective board of directors is not just a formality—it’s a strategic asset. This white paper outlines eight common “temptations” that can undermine CEO-board effectiveness and offers tactical approaches to foster trust, alignment, and impactful decision-making.

Click here to download this free resource today.